Loading clinical trials...
Loading clinical trials...
An Open-Label Extension of a Randomized, Multicenter, Double-Masked, Vehicle-Controlled Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
Conditions
Interventions
OTX-101 0.09%
Start Date
July 29, 2016
Primary Completion Date
August 15, 2017
Completion Date
August 15, 2017
Last Updated
November 19, 2021
NCT03925727
NCT03418259
NCT02688556
NCT01797822
NCT02665234
NCT03408015
Lead Sponsor
Sun Pharmaceutical Industries Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions